ERBB2 and triple-negative breast carcinoma: This result was consistent with all the subtypes, estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2−), HER2 positive (HER2+) and triple negative breast cancer (TNBC) (Fig. 1).